1. MicroRNA-187 induces diffuse large B-cell lymphoma cell apoptosis via targeting BCL6
   FANG HUANG et al, 2016, Oncology Letters CrossRef
2. FXYD5 promotes sorafenib resistance through the Akt/mTOR signaling pathway in hepatocellular carcinoma
   Xiang-Peng Tan et al, 2022, European Journal of Pharmacology CrossRef
3. Targeting liver cancer stem cells for the treatment of hepatocellular carcinoma
   Na Li et al, 2019, Therapeutic Advances in Gastroenterology CrossRef
4. Roles of mitochondria in liver cancer stem cells
   Ching-Wen Chang et al, 2019, Differentiation CrossRef
5. Potential targets and therapeutics for cancer stem cell-based therapy against drug resistance in hepatocellular carcinoma
   Hongxing Zhao et al, 2024, Drug Resistance Updates CrossRef
6. The bad seed gardener: Deubiquitinases in the cancer stem-cell signaling network and therapeutic resistance
   Guan-Zhong Qiu et al, 2017, Pharmacology & Therapeutics CrossRef
7. MMP8 increases tongue carcinoma cell–cell adhesion and diminishes migration via cleavage of anti-adhesive FXYD5
   K. Juurikka et al, 2021, Oncogenesis CrossRef
8. FXYD5 (Dysadherin) upregulation predicts shorter survival and reveals platinum resistance in high-grade serous ovarian cancer patients
   Renata A. Tassi et al, 2019, British Journal of Cancer CrossRef